article thumbnail

MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation

Cannabis Law Report

Studies estimate that the number of people suffering from rheumatoid arthritis may rise to over 78 million by 2040. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

article thumbnail

Euro & UK Roundup: Czech Republic, Ireland, San Marino, UK

Cannabis Law Report

24 people in Ireland are now being prescribed medicinal cannabis, but it only includes those suffering from multiple sclerosis, epilepsy and post chemotherapy sickness. Good news for epilepsy patients because UK authorities have finally given their nod for Epidiolex. San Marino.